Neutropenia and myelodysplasia arise from Sbds defects on haematopoietic and osteoprogenitor cells respectively48, therefore correction of hyper-activation of JAK/STAT/mTOR pathways is expected to correct both deficiencies. This evidence concerns the gene SBDS and Myelodysplasia.